Indications
- dissolution of cholesterol gallstones in patients with high surgical risk and in patients after lithotripsy. The prerequisite for successful treatment is a functioning gallbladder and the presence of clear radiotransparent cholesterol stones, the diameter of which does not exceed 2 cm;
- primary biliary cirrhosis of liver of stage I and II;
- primary sclerosing cholangitis;
- hepatitis (chronic, active including atypical forms of chronic autoimmune hepatitis, chronic and acute viral hepatitis);
- non-alcoholic steatohepatitis;
- toxic (including alcoholic, drug-induced) liver damage;
- cystic fibrosis (cystic fibrosis of the liver);
- biliary reflux gastritis;
- biliary reflux esophagitis;
- biliary dyspepsia;
- biliary dyskinesias;
- cholestatic liver diseases in children (including bile duct atresia);
- cholestasis after liver transplantation;
- chronic opisthorchiasis;
- prevention of colorectal cancer in patients at high risk of its development (e.g. ulcerative colitis);
- prevention of biliary calculi formation in obese patients during rapid weight loss.
Information on proper use
How to use and dosage
Gepaluks® is intended for oral use. Capsules are taken orally, regardless of food intake, it is desirable to take the drug in the evening before going to bed drinking enough liquid. Dosing regimen and duration of treatment are established individually and depend on the indications, severity of the patient's condition.
The average dosage is 8-10 mg/kg/day for 6-12 months.
